Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-uPAR/PLAUR Antibody (4P835)
😃Good
Catalog No. TMAY-01338
Alias URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87
Anti-uPAR/PLAUR Antibody (4P835) is a Rabbit antibody targeting uPAR/PLAUR. Anti-uPAR/PLAUR Antibody (4P835) can be used in ELISA.
Anti-uPAR/PLAUR Antibody (4P835)
Anti-uPAR/PLAUR Antibody (4P835)
😃Good
Catalog No. TMAY-01338Alias URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87
Anti-uPAR/PLAUR Antibody (4P835) is a Rabbit antibody targeting uPAR/PLAUR. Anti-uPAR/PLAUR Antibody (4P835) can be used in ELISA.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μL | $269 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Rabbit Monoclonal Application: ELISA Reactivity: Human |
| Alias | URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87 |
| Ig Type | Rabbit IgG |
| Clone | 4P835 |
| Reactivity | Human |
| Application | ELISA |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human PLAUR / CD87 / uPAR (rh PLAUR / CD87 / uPAR; TMPY-02141; Q03405-1; Met1-Arg303). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Urokinase plasminogen activator (uPA) and/or its receptor (uPAR) are essential for metastasis, and overexpression of these molecules is strongly correlated with poor prognosis in a variety of malignant tumours. uPAR and uPA levels in both resected tumor tissue and plasma are of independent prognostic significance for patient survival in several types of human cancer. This system has classically been thought to drive tumor progression by mediating directed extracellular proteolysis on the surface of migrating or invading cells, and intervening with this proteolysis by targeting uPAR has been proposed to represent a novel approach for inhibiting tumor progression. uPAR, also known as PLAUR or CD87, has been implicated in the growth, metastasis, and angiogenesis of several solid and hemotologic malignancies. uPAR is a highly glycosylated, 55-60kDa integral membrane protein linked to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor. It is part of a cell surface system that also consists of the serine protease uPA and several specific inhibitors (plasminogen activator inhibitors 1 and 2). Additionally, the analysis of CD87 (urokinase-type plasminogen activator receptor - uPAR) expression has a potential role in the diagnostic or prognostic work-up of several hematological malignancies, particularly acute leukemia and multiple myeloma. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human PLAUR / CD87 / uPAR protein (TMPY-02141) |
| Antigen Species | Human |
| Biology Area | Serine Proteases and Regulators |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-uPAR/PLAUR Antibody (4P835) | purchase Anti-uPAR/PLAUR Antibody (4P835) | Anti-uPAR/PLAUR Antibody (4P835) cost | order Anti-uPAR/PLAUR Antibody (4P835)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.